9999999995-24-000271.txt : 20240201 9999999995-24-000271.hdr.sgml : 20240201 20240201001524 ACCESSION NUMBER: 9999999995-24-000271 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240201 EFFECTIVENESS DATE: 20240131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BriaCell Therapeutics Corp. CENTRAL INDEX KEY: 0001610820 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-276650 FILM NUMBER: 24584885 BUSINESS ADDRESS: STREET 1: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR CITY: WEST VANCOUVER STATE: A1 ZIP: V7T 2X1 BUSINESS PHONE: (604) 921-1810 MAIL ADDRESS: STREET 1: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR CITY: WEST VANCOUVER STATE: A1 ZIP: V7T 2X1 FORMER COMPANY: FORMER CONFORMED NAME: Ansell Capital Corp. DATE OF NAME CHANGE: 20140613 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2024-01-31 17:00:00

S-3

0001610820 BriaCell Therapeutics Corp. 333-276650